Medical Xpress news

Medical Xpress / Trojan horse delivery system uses gold nanoparticles to drive mRNA into tumors

University of Oklahoma researchers have created a new drug delivery system that helps cancer cells take in much more of a treatment, improving its ability to kill tumors. The findings are published in Science Advances.

Feb 5, 2026 in Oncology & Cancer
Medical Xpress / Immune cells linked to Epstein-Barr virus may play a role in multiple sclerosis

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million Americans. The work found ...

Medical Xpress / AI tool predicts brain age, cancer survival and other disease signals from unlabeled brain MRIs

Mass General Brigham investigators have developed a robust new artificial intelligence (AI) foundation model that is capable of analyzing brain MRI datasets to perform numerous medical tasks, including identifying brain age, ...

Feb 5, 2026 in Health informatics
Medical Xpress / Family dinners may reduce substance-use risk for many adolescents

A new study by researchers at Tufts University School of Medicine finds that regular family dinners may help prevent substance use for a majority of U.S. adolescents, but suggests that the strategy is not effective for youth ...

Feb 5, 2026 in Health
Medical Xpress / Extreme temperature changes increase number of out-of-hospital cardiac arrests, model finds

Out-of-hospital cardiac arrest, or OHCA, is a leading cause of mortality worldwide and 90% of cases are fatal. Patients lose cardiac function and circulation, and every minute they remain untreated decreases the likelihood ...

Feb 5, 2026 in Cardiology
Medical Xpress / Choline could reduce pregnancy inflammation, study suggests

Pregnancy is, biologically speaking, a state of controlled upheaval. The immune system recalibrates. Blood volume surges. And sometimes, inflammation rises to unsafe levels, with potential adverse health effects for both ...

Feb 5, 2026 in Obstetrics & gynaecology
Medical Xpress / Fentanyl is changing how doctors treat opioid use disorder

For years, buprenorphine—one of the primary medications used to treat opioid use disorder—has been a critical bridge to recovery, helping to reduce illicit drug use and overdose deaths. But with the changing landscape ...

Feb 5, 2026 in Addiction
Medical Xpress / Gut microbe-derived butyrate activates immune cells to enhance vaccine efficacy

A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing how butyrate—a short-chain fatty acid produced by gut commensal bacteria—enhances T follicular ...

Feb 5, 2026 in Immunology
Medical Xpress / Post-Dobbs state abortion bans tied to higher postpartum depression risk in low‑income communities

A new national study of Medicaid enrollees finds that postpartum depression (PPD) rose significantly among women and adolescents living in low-income areas of states that banned or severely restricted abortion following the ...

Feb 5, 2026 in Psychology & Psychiatry
Medical Xpress / Clopidogrel shown to be superior to aspirin for long-term antiplatelet therapy after coronary stenting

A research team has demonstrated that clopidogrel is more effective than aspirin as a long-term antiplatelet therapy in patients at high risk of recurrent cardiovascular events after coronary stent implantation. The team ...

Feb 5, 2026 in Cardiology
Medical Xpress / Why antibiotic allergy labels deserve a second look

In modern medicine, antibiotics are among the most powerful tools for preventing and treating life-threatening bacterial infections. Their effectiveness, however, often depends on using the right drug at the right time. Recognizing ...

Feb 5, 2026 in Medications
Medical Xpress / Five mutational 'fingerprints' could help predict how visible tumors are to the immune system

Researchers from the HUN-REN Szeged Biological Research Centre and HCEMM have just published a new study suggesting that it's not simply the number of tumor mutations that matters for immunotherapy, but the kind of mutation ...

Feb 5, 2026 in Oncology & Cancer